Agios Pharmaceuticals
AGIO
AGIO
159 hedge funds and large institutions have $1.7B invested in Agios Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 47 increasing their positions, 58 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less call options, than puts
Call options by funds: $8.77M | Put options by funds: $10.1M
19% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 58
Holders
159
Holding in Top 10
–
Calls
$8.77M
Puts
$10.1M
Top Buyers
| 1 | +$10M | |
| 2 | +$8.45M | |
| 3 | +$8.3M | |
| 4 |
Axa
Paris,
France
|
+$5.85M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.64M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$6.4M | |
| 3 | -$6.01M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.16M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.07M |